Balance Sheet Components (Tables)

12 Months Ended

Dec. 31, 2024

Balance Sheet Related Disclosures [Abstract]

Balance Sheet Components

Accrued liabilities consist of the following (in thousands):

	December 31,		December 31,
	2024		2023
Accrued clinical trial-related expenses	$	2,377	$	4,809
Accrued research and development-related expenses		1,974		1,746
Accrued professional services expenses		52		24
Other		51		102
Total accrued liabilities	$	4,454	$	6,681